A novel mutation deep within intron 7 of the GBA gene causes Gaucher disease
Abstract Background Mutations in the GBA gene that encodes the lysosomal enzyme acid β‐glucocerebrosidase cause Gaucher disease (GD), the most common lysosomal storage disorder. Most of the mutations are missense/nonsense, however, a few splicing mutations within or close to conserved consensus dono...
| Published in: | Molecular Genetics & Genomic Medicine |
|---|---|
| Main Authors: | Anna Malekkou, Ioanna Sevastou, Gavriella Mavrikiou, Theodoros Georgiou, Lluisa Vilageliu, Marina Moraitou, Helen Michelakakis, Chrystalla Prokopiou, Anthi Drousiotou |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-03-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/mgg3.1090 |
Similar Items
The GBA p.G85E mutation in Korean patients with non-neuronopathic Gaucher disease: founder and neuroprotective effects
by: Yoo-Mi Kim, et al.
Published: (2020-11-01)
by: Yoo-Mi Kim, et al.
Published: (2020-11-01)
Case Study of a Rare Genetic Disorder: Gaucher Disease
by: A. Xani, et al.
Published: (2025-06-01)
by: A. Xani, et al.
Published: (2025-06-01)
The Spectrum of Neurological Manifestations Associated with Gaucher Disease
by: Tamanna Roshan Lal, et al.
Published: (2017-03-01)
by: Tamanna Roshan Lal, et al.
Published: (2017-03-01)
Expert consensus guideline on the diagnosis of type 1 Gaucher disease in adult patients
by: Antonio De Vivo, et al.
Published: (2024-06-01)
by: Antonio De Vivo, et al.
Published: (2024-06-01)
Functional Analysis of Human <i>GBA1</i> Missense Mutations in <i>Drosophila</i>: Insights into Gaucher Disease Pathogenesis and Phenotypic Consequences
by: Aparna Kuppuramalingam, et al.
Published: (2024-09-01)
by: Aparna Kuppuramalingam, et al.
Published: (2024-09-01)
Thrombocytopenia and GBA gene mutation in a patient with adult type 1 Gaucher disease
by: Lagen Wan, et al.
Published: (2017-11-01)
by: Lagen Wan, et al.
Published: (2017-11-01)
The Uncovered Function of the <i>Drosophila GBA1a</i>-Encoded Protein
by: Or Cabasso, et al.
Published: (2021-03-01)
by: Or Cabasso, et al.
Published: (2021-03-01)
GBA1 variants in Brazilian Gaucher disease patients
by: Suelen Porto Basgalupp, et al.
Published: (2023-12-01)
by: Suelen Porto Basgalupp, et al.
Published: (2023-12-01)
Gaucher disease type 2 (case report)
by: D. R. Shagieva, et al.
Published: (2020-09-01)
by: D. R. Shagieva, et al.
Published: (2020-09-01)
Gaucher disease type 3c: Expanding the clinical spectrum of an ultra‐rare disease
by: John S. Wang, et al.
Published: (2024-09-01)
by: John S. Wang, et al.
Published: (2024-09-01)
Blood Glucocerebrosidase Activity and α-Synuclein Levels in Patients with GBA1-Associated Parkinson's Disease and Asymptomatic <i>GBA1</i> Mutation Carriers
by: Anton K. Emelyanov, et al.
Published: (2024-10-01)
by: Anton K. Emelyanov, et al.
Published: (2024-10-01)
Autophagic dysregulation triggers innate immune activation in glucocerebrosidase deficiency
by: Magda L. Atilano, et al.
Published: (2024-12-01)
by: Magda L. Atilano, et al.
Published: (2024-12-01)
D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model
by: Donghoon Kim, et al.
Published: (2018-04-01)
by: Donghoon Kim, et al.
Published: (2018-04-01)
Neurosteroid Levels in GBA Mutated and Non-Mutated Parkinson’s Disease: A Possible Factor Influencing Clinical Phenotype?
by: Francesco Cavallieri, et al.
Published: (2024-08-01)
by: Francesco Cavallieri, et al.
Published: (2024-08-01)
Perinatal lethal Gaucher disease due to compound heterozygosity of the splicing mutations in GBA gene
by: Tsai-Jung Lu, et al.
Published: (2023-01-01)
by: Tsai-Jung Lu, et al.
Published: (2023-01-01)
Perinatal-lethal Gaucher disease can be the underlying cause of congenital ichthyosis
by: Kubra Baskin, et al.
Published: (2019-07-01)
by: Kubra Baskin, et al.
Published: (2019-07-01)
GBA1 as a risk gene for osteoporosis in the specific populations and its role in the development of Gaucher disease
by: Chung-Hsing Wang, et al.
Published: (2024-04-01)
by: Chung-Hsing Wang, et al.
Published: (2024-04-01)
Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease
by: Giulietta Maria Riboldi, et al.
Published: (2022-08-01)
by: Giulietta Maria Riboldi, et al.
Published: (2022-08-01)
<i>GBA</i>, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches
by: Giulietta M. Riboldi, et al.
Published: (2019-04-01)
by: Giulietta M. Riboldi, et al.
Published: (2019-04-01)
Viral delivery of a microRNA to Gba to the mouse central nervous system models neuronopathic Gaucher disease
by: Kasey L. Jackson, et al.
Published: (2019-10-01)
by: Kasey L. Jackson, et al.
Published: (2019-10-01)
Gaucher's disease - a review of the most important information about the disease in Paediatrics
by: Jakub Jarmołowicz, et al.
Published: (2025-07-01)
by: Jakub Jarmołowicz, et al.
Published: (2025-07-01)
Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease
by: Laura J. Smith, et al.
Published: (2022-08-01)
by: Laura J. Smith, et al.
Published: (2022-08-01)
Neurocognitive profile of adults with the Norrbottnian type of Gaucher disease
by: Panagiota Tsitsi, et al.
Published: (2022-01-01)
by: Panagiota Tsitsi, et al.
Published: (2022-01-01)
Comparative analysis of methods for measuring glucocerebrosidase enzyme activity in patients with Parkinson’s disease with the GBA1 variant
by: Jin Hwangbo, et al.
Published: (2025-04-01)
by: Jin Hwangbo, et al.
Published: (2025-04-01)
Association Between Progranulin and Gaucher Disease
by: Jinlong Jian, et al.
Published: (2016-09-01)
by: Jinlong Jian, et al.
Published: (2016-09-01)
A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease
by: Wendy Westbroek, et al.
Published: (2016-07-01)
by: Wendy Westbroek, et al.
Published: (2016-07-01)
Application of CRISPR/Cas9 technology in the modeling of Gaucher disorder
by: Mehran Reyhani-Ardabili, et al.
Published: (2024-12-01)
by: Mehran Reyhani-Ardabili, et al.
Published: (2024-12-01)
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
by: Xuxiang Zhang, et al.
Published: (2024-09-01)
by: Xuxiang Zhang, et al.
Published: (2024-09-01)
Exploring the relationship between GBA1 host genotype and gut microbiome in the GBA1L444P/WT mouse model: implications for Parkinson’s disease pathogenesis
by: Elisa Menozzi, et al.
Published: (2025-10-01)
by: Elisa Menozzi, et al.
Published: (2025-10-01)
Gaucher disease: achievements and prospects
by: Rodion V. Ponomarev, et al.
Published: (2021-07-01)
by: Rodion V. Ponomarev, et al.
Published: (2021-07-01)
The molecular mechanism of Gaucher disease caused by compound heterozygous mutations in GBA1 gene
by: Qi Liu, et al.
Published: (2023-01-01)
by: Qi Liu, et al.
Published: (2023-01-01)
Type 1 and Type 3 Gaucher Disease in Two Siblings in A Family: 2 Unusual Case Reports
by: DOLANCHAMPA MODAK, et al.
Published: (2015-02-01)
by: DOLANCHAMPA MODAK, et al.
Published: (2015-02-01)
Case report: Multidisciplinary collaboration in diagnosis and treatment of child gaucher disease
by: Jianfang Zhu, et al.
Published: (2023-03-01)
by: Jianfang Zhu, et al.
Published: (2023-03-01)
Rapid and long‐lasting efficacy of high‐dose ambroxol therapy for neuronopathic Gaucher disease: A case report and literature review
by: Kanako Higashi, et al.
Published: (2024-04-01)
by: Kanako Higashi, et al.
Published: (2024-04-01)
Une déformation du fémur en flacon d'Erlenmeyer: la maladie de Gaucher
by: Faten Frikha, et al.
Published: (2015-04-01)
by: Faten Frikha, et al.
Published: (2015-04-01)
Enhanced calcium release in the acute neuronopathic form of Gaucher disease
by: Dori Pelled, et al.
Published: (2005-02-01)
by: Dori Pelled, et al.
Published: (2005-02-01)
A rare homozygous p.Arg87Trp variant of the GBA gene in Gaucher disease: A case report
by: Houweyda Jilani, et al.
Published: (2022-05-01)
by: Houweyda Jilani, et al.
Published: (2022-05-01)
Phenotypic Heterogeneity among <i>GBA</i> p.R202X Carriers in Lewy Body Spectrum Disorders
by: Valerio Napolioni, et al.
Published: (2022-01-01)
by: Valerio Napolioni, et al.
Published: (2022-01-01)
GBA1 inactivation in oligodendrocytes affects myelination and induces neurodegenerative hallmarks and lipid dyshomeostasis in mice
by: Ilaria Gregorio, et al.
Published: (2024-03-01)
by: Ilaria Gregorio, et al.
Published: (2024-03-01)
Characterization of the genotypes of patients with Gaucher disease type 1 in the Russian Federation
by: K A Lukina, et al.
Published: (2013-07-01)
by: K A Lukina, et al.
Published: (2013-07-01)
Similar Items
-
The GBA p.G85E mutation in Korean patients with non-neuronopathic Gaucher disease: founder and neuroprotective effects
by: Yoo-Mi Kim, et al.
Published: (2020-11-01) -
Case Study of a Rare Genetic Disorder: Gaucher Disease
by: A. Xani, et al.
Published: (2025-06-01) -
The Spectrum of Neurological Manifestations Associated with Gaucher Disease
by: Tamanna Roshan Lal, et al.
Published: (2017-03-01) -
Expert consensus guideline on the diagnosis of type 1 Gaucher disease in adult patients
by: Antonio De Vivo, et al.
Published: (2024-06-01) -
Functional Analysis of Human <i>GBA1</i> Missense Mutations in <i>Drosophila</i>: Insights into Gaucher Disease Pathogenesis and Phenotypic Consequences
by: Aparna Kuppuramalingam, et al.
Published: (2024-09-01)
